Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ovarian Cancer, Ovarian Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05734287
What this trial is testing

The Frequency of Polycystic Ovary Syndrome Among Young Reproductive Females Presenting With Hyperandrogenism: a Mixed Cohort Study

Who this might be right for
PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
Woman's Health University Hospital, Egypt 260
Not applicableUnknownNCT00319293
What this trial is testing

Efficacy of Metformin in Lean Women With Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary Syndrome
Aarhus University Hospital Skejby 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03579316
What this trial is testing

Adavosertib With or Without Olaparib in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
M.D. Anderson Cancer Center 96
Testing effectiveness (Phase 2)Ended earlyNCT02469116
What this trial is testing

Carboplatin Plus Docetaxel With Day 2 Pegylated G-CSF (Neulasta®) in Patients With Advanced Stage Ovarian Carcinoma

Who this might be right for
Ovarian Cancer
Washington University School of Medicine 18
Not applicableUnknownNCT02190006
What this trial is testing

Comparison Between the Role of Follicular Output Rate and Preovulatory Count in the Prediction of Pregnancy in Women With Polycystic Ovarian Syndrome Undergoing Intra Cytoplasmic Sperm Injection (ICSI)

Who this might be right for
Polycystic Ovarian SyndromeSubfertilityICSI
Cairo University 300
Not applicableLooking for participantsNCT07298564
What this trial is testing

Effect of Magnesium and Levocarnitine on Metabolic and Clinical Outcomes in Women With Polycystic Ovarian Syndrome (PCOS)

Who this might be right for
Polycystic Ovary Syndrome (PCOS)
Behnood Abbasi 84
Not applicableLooking for participantsNCT07125209
What this trial is testing

Cognitive Impact of Neoadjuvant Chemotherapy for Gynecologic Cancers

Who this might be right for
Ovarian CancerCognitive Change
University of Wisconsin, Madison 18
Not applicableUnknownNCT05830487
What this trial is testing

Advanced Glycation End Products and Dietary Intervention in Polycystic Ovary Patients

Who this might be right for
Polycystic Ovary SyndromeDiet Habit
Hacettepe University 24
Large-scale testing (Phase 3)Active Not RecruitingNCT02655016
What this trial is testing

Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

Who this might be right for
Ovarian Neoplasms
Tesaro, Inc. 733
Post-approval studies (Phase 4)Study completedNCT01779232
What this trial is testing

Danazol Treatment in Endometriosis Women Before IVF

Who this might be right for
EndometriosisOvarian CystsInfertility
Centre for Endocrinology and Reproductive Medicine, Italy 150
Early research (Phase 1)Active Not RecruitingNCT04616534
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors

Who this might be right for
Advanced Fallopian Tube CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian Carcinoma+19 more
National Cancer Institute (NCI) 14
Early research (Phase 1)Study completedNCT00877253
What this trial is testing

Determine MTD, Evaluate Efficacy and Safety of Genexol®-PM Plus Carboplatin With Advanced Ovarian Cancer

Who this might be right for
Ovarian Cancer
Samyang Biopharmaceuticals Corporation 18
Large-scale testing (Phase 3)Looking for participantsNCT05804370
What this trial is testing

Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)

Who this might be right for
Ovarian Cancer
NX Development Corp 170
Early research (Phase 1)Study completedNCT01248273
What this trial is testing

Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission

Who this might be right for
Fallopian TubesOvarian CancerPeritoneal Cancer
Memorial Sloan Kettering Cancer Center 26
Early research (Phase 1)Study completedNCT02960594
What this trial is testing

HTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse

Who this might be right for
Breast CancerLung CancerPancreatic Cancer+6 more
Inovio Pharmaceuticals 93
Not applicableEnded earlyNCT00003794
What this trial is testing

Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer

Who this might be right for
Ovarian Cancer
Gynecologic Oncology Group
Not applicableStudy completedNCT05428566
What this trial is testing

A Comparison of a PULSE Diet and the TLC Diet on Reproductive, Metabolic Parameters in Women with PCOS

Who this might be right for
Polycystic Ovary SyndromeMetabolic Syndrome
University of Jordan 144
Not applicableUnknownNCT02952183
What this trial is testing

Efficacy of Pelvic Autonomic Nerve Monitoring System (PAMS I) in Female Patients With Pelvic Tumors

Who this might be right for
Cervical CancerUterine CancerOvarian Cancer
Seoul National University Hospital 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07797283
What this trial is testing

Phase 3 Study of INCB123667 Plus Bevacizumab Versus Bevacizumab Alone as First-Line Maintenance Therapy in Ovarian Cancer Overexpressing Cyclin E1

Who this might be right for
Ovarian Cancer
Incyte Corporation 590
Not applicableUnknownNCT04474951
What this trial is testing

Food Supplements Based on Nettle and Peppermint to Control Signs and Symptoms Induced by Cancer Therapies

Who this might be right for
Breast CancerGynecologic Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna 60
Next Page